Replies to post #1806 on Viking Therapeutics Inc (VKTX)

[roadkilll]

Update the previous post
08/13/2021 7,377,030
07/15/2019.. 22,751,462 shares short

Madrigal has an open label phase III trial on it's orally available small molecule thyroid hormone receptor agonist that possesses selectivity for liver tissue.

Viking is riding it's coattails with what will become the drug of choice. 100mg dose vs 1mg dose with similar molecular weights.